Geode Capital Management
BSX icon

Geode Capital Management’s Boston Scientific BSX Stock Holding History

Geode Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.08B Buy
33,285,757
+901,992
+3% +$72.2M 0.13% 129
2025
Q4 		$3.07B Sell
32,383,765
-306,763
-0.9% -$30.1M 0.19% 85
2025
Q3 		$3.18B Buy
32,690,528
+265,546
+0.8% +$27.5M 0.2% 84
2025
Q2 		$3.47B Buy
32,424,982
+622,602
+2% +$63M 0.24% 65
2025
Q1 		$3.2B Buy
31,802,380
+1,176,210
+4% +$118M 0.25% 67
2024
Q4 		$2.73B Buy
30,626,170
+1,041,329
+4% +$91.7M 0.21% 74
2024
Q3 		$2.47B Buy
29,584,841
+480,729
+2% +$37.9M 0.2% 86
2024
Q2 		$2.23B Buy
29,104,112
+651,449
+2% +$47.7M 0.2% 87
2024
Q1 		$1.94B Buy
28,452,663
+896,448
+3% +$57.6M 0.18% 100
2023
Q4 		$1.59B Buy
27,556,215
+559,898
+2% +$29.9M 0.17% 107
2023
Q3 		$1.42B Buy
26,996,317
+948,203
+4% +$49.7M 0.17% 109
2023
Q2 		$1.4B Buy
26,048,114
+718,985
+3% +$37.6M 0.17% 108
2023
Q1 		$1.26B Buy
25,329,129
+473,888
+2% +$22.3M 0.16% 112
2022
Q4 		$1.15B Buy
24,855,241
+549,599
+2% +$23.8M 0.16% 118
2022
Q3 		$940M Buy
24,305,642
+532,217
+2% +$21.4M 0.14% 130
2022
Q2 		$884M Buy
23,773,425
+712,836
+3% +$29M 0.13% 142
2022
Q1 		$1.02B Buy
23,060,589
+706,421
+3% +$30.6M 0.13% 138
2021
Q4 		$947M Buy
22,354,168
+375,333
+2% +$15.8M 0.11% 158
2021
Q3 		$951M Buy
21,978,835
+766,495
+4% +$33.9M 0.13% 134
2021
Q2 		$904M Buy
21,212,340
+529,430
+3% +$22.3M 0.12% 139
2021
Q1 		$797M Buy
20,682,910
+201,060
+1% +$7.61M 0.12% 144
2020
Q4 		$734M Buy
20,481,850
+176,607
+0.9% +$6.37M 0.12% 142
2020
Q3 		$774M Sell
20,305,243
-61,032
-0.3% -$2.35M 0.15% 127
2020
Q2 		$714M Buy
20,366,275
+1,301,314
+7% +$46.9M 0.15% 128
2020
Q1 		$621M Buy
19,064,961
+53,382
+0.3% +$2.09M 0.16% 128
2019
Q4 		$858M Buy
19,011,579
+449,091
+2% +$18.8M 0.18% 109
2019
Q3 		$754M Buy
18,562,488
+471,694
+3% +$20M 0.18% 111
2019
Q2 		$776M Buy
18,090,794
+301,465
+2% +$11.6M 0.19% 100
2019
Q1 		$681M Buy
17,789,329
+807,327
+5% +$30.8M 0.18% 106
2018
Q4 		$599M Buy
16,982,002
+1,724,046
+11% +$62.5M 0.19% 99
2018
Q3 		$586M Buy
15,257,956
+742,095
+5% +$25.9M 0.17% 115
2018
Q2 		$474M Buy
14,515,861
+650,692
+5% +$19.6M 0.15% 134
2018
Q1 		$378M Buy
13,865,169
+824,182
+6% +$22.4M 0.12% 172
2017
Q4 		$323M Buy
13,040,987
+373,607
+3% +$10.3M 0.11% 188
2017
Q3 		$369M Buy
12,667,380
+271,913
+2% +$7.51M 0.14% 144
2017
Q2 		$343M Buy
12,395,467
+275,093
+2% +$7.3M 0.13% 149
2017
Q1 		$301M Buy
12,120,374
+888,331
+8% +$21.6M 0.12% 164
2016
Q4 		$243M Buy
11,232,043
+592,279
+6% +$12.9M 0.11% 180
2016
Q3 		$253M Buy
10,639,764
+340,296
+3% +$8.12M 0.13% 160
2016
Q2 		$240M Sell
10,299,468
-668,406
-6% -$14.5M 0.13% 149
2016
Q1 		$206K Buy
10,967,874
+253,069
+2% +$4.45M 0.11% 180
2015
Q4 		$197M Buy
10,714,805
+9,034
+0.1% +$162K 0.11% 179
2015
Q3 		$175M Buy
10,705,771
+128,123
+1% +$2.19M 0.11% 197
2015
Q2 		$187M Buy
10,577,648
+105,622
+1% +$1.89M 0.11% 191
2015
Q1 		$186M Buy
10,472,026
+148,672
+1% +$2.35M 0.11% 197
2014
Q4 		$137M Buy
10,323,354
+594,377
+6% +$7.6M 0.08% 254
2014
Q3 		$115M Sell
9,728,977
-40,107
-0.4% -$505K 0.07% 268
2014
Q2 		$125M Sell
9,769,084
-110,460
-1% -$1.44M 0.08% 247
2014
Q1 		$134M Sell
9,879,544
-35,816
-0.4% -$470K 0.09% 229
2013
Q4 		$119M Buy
9,915,360
+454,842
+5% +$5.37M 0.08% 246
2013
Q3 		$111M Buy
9,460,518
+305,601
+3% +$3.31M 0.09% 231
2013
Q2 		$84.8M Buy
+9,154,917
New +$77.7M 0.07% 280

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management's BSX Position: Q1 2026 in Review

Geode Capital Management increased its Boston Scientific (BSX) stake by 2.8% in Q1 2026, buying an estimated $72.2M and bringing the position to 33,285,757 shares worth $2.08B. The position accounts for 0.13% of the portfolio, ranked #129.

Geode Capital Management first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.47B in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Geode Capital Management held 33,285,757 shares of Boston Scientific worth $2.08B as of Q1 2026.
  • Geode Capital Management bought 901,992 Boston Scientific shares in Q1 2026, an estimated $72.2M.
  • Boston Scientific made up 0.13% of Geode Capital Management's portfolio in Q1 2026, its #129 holding.
  • Geode Capital Management first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
  • Geode Capital Management's Boston Scientific position peaked at $3.47B in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.